01—Abstract
Summary
Summary of the 8-K filed April 26, 2023. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. (CME) has filed a Form 8-K on April 26, 2023, to report its financial results for the quarter ended March 31, 2023.
The filing primarily incorporates by reference a press release (Exhibit 99.1) containing these results. Investors should note that while the press release presents financial information on a GAAP basis, it also includes non-GAAP measures such as non-GAAP net income and earnings per share. Management utilizes these non-GAAP figures to offer supplemental insights into financial and business trends, believing they enhance comparability with prior periods.
A reconciliation between GAAP and non-GAAP measures is provided within the press release as required by Regulation G. The core of this report for investors lies in the details contained within the referenced press release.
While the 8-K itself does not provide the specific figures, it directs stakeholders to the April 26, 2023, press release for the definitive financial performance of CME Group for the first quarter of 2023. Investors are advised to review this press release for key metrics, revenue drivers, profitability, and any forward-looking statements or management commentary regarding the company's performance and outlook.
02—Key points
Key Highlights
- CME Group Inc. filed an 8-K on April 26, 2023, reporting Q1 2023 financial results.
- The primary disclosure is contained within an attached press release (Exhibit 99.1).
- The press release includes both GAAP and non-GAAP financial measures (net income, EPS).
- Non-GAAP measures are presented to provide supplemental information and enhance comparability.
- A reconciliation between GAAP and non-GAAP financial measures is included in the press release.
- Investors should refer to the April 26, 2023 press release for detailed financial performance figures.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K filing?
The main purpose of this 8-K filing is to report CME Group Inc.'s financial results for the quarter ended March 31, 2023. The detailed financial information is provided in an accompanying press release.
What are the key financial measures discussed in the filing?
The filing mentions that the accompanying press release includes both Generally Accepted Accounting Principles (GAAP) financial measures and non-GAAP financial measures, specifically non-GAAP net income and earnings per share.
Why does CME Group present non-GAAP financial measures?
CME Group presents non-GAAP financial measures to provide important supplemental information to management and investors about financial and business trends. Management believes these measures offer better comparability with the company's prior financial reports.
Where can I find the actual financial results for Q1 2023?
The actual financial results, including detailed figures and reconciliations, are located in the press release dated April 26, 2023, which is attached as Exhibit 99.1 to this 8-K filing.
04—Continue